cGxP.wire https://validator.w3.org/feed/docs/rss2.html Aligos Therapeutics Gains Fast Track for HBV Drug AOP Health Wins FDA Approval for Rapiblyk in Pediatric SVT Radical Catheter Gains FDA Clearance for 6F Device BioVersys Starts Phase 3 BV100 Pneumonia Trial LEO Pharma Gains FDA sNDA Acceptance for ANZUPGO Leadiant Biosciences Secures Canada Approval for Cysklar Bavarian Nordic Wins Swiss Approval for Chikungunya Vaccine Eli Lilly to Acquire CrossBridge Bio for ADC Platform Savara Inc. Gets FDA Extension for Molgramostim Review Boehringer Ingelheim, Zai Lab Advance DLL3 Cancer Trial Tempus AI, Predicta Expand Genomics Test for Blood Cancer Precision BioSciences Expands ELIMINATE-B Trial in EU Organon VTAMA Cream Gains Strong AAD Guideline Support Dogwood Secures FDA IND Nod for SP16 Pain Therapy Immutep Secures FDA Orphan Status for Efti in Sarcoma ARS Pharma Wins Canada Nod for Needle-Free Epinephrine Telix Doses First Patient in Phase 3 Glioblastoma Trial Clarity Signs Deal to Boost Prostate Cancer Imaging Supply Cala Health Gains FDA Clearance for kIQ Plus Device XellSmart Advances Phase 2 Parkinson’s Cell Therapy Trial Boehringer Introduces LENZELTA Vaccine for Mastitis Control TOBY Gains FDA Breakthrough Status for MCED Test Mabwell Advances SST001 PET Tracer to Phase I Trial Apotex Secures FDA Approval for Generic Infuvite Injection Partner Therapeutics Files sBLA for BIZENGRI in CCA Protaryx Wins FDA 510(k) Clearance for Cardiac Device Avanos to Be Acquired by AIP in $1.27B Deal GlycoNex Secures PMDA Nod for GNX1021 Phase 1 Trial Revolution Medicines Reports Phase 3 Survival Gain PDAC Neurocrine Shows INGREZZA Persistence Edge in TD Study SynOx Phase 3 Study Shows TGCT Treatment Benefit BioOra and Cincinnati Advance CAR-T Therapy in Leukemia Penumbra Shows Strong Outcomes in STORM-PE Study Akebia Therapeutics Doses First in AKB-9090 Trial Endpoint Clinical Launches Elosity R3 AI Trial Platform Travere Therapeutics Wins FDA Approval for FILSPARI in FSGS Septerna Initiates SEP-479 Phase 1 Hypoparathyroidism Personalis Advances ctDNA Cancer Monitoring with AI Platform Sirtex Medical Reports 100% Tumor Control in DOORwaY90 Enanta Pharma Advances EDP-978 Phase 1 Urticaria Drug GSK Reports Strong ADC Data in Ovarian Cancer Study Telix and Regeneron Partner to Advance Radiopharma Therapies Ocular Therapeutix AXPAXLI Shows Strong Phase 3 AMD Vivatides Therapeutics Raises $54M to Expand RNA Therapies Covalon Advances Infection Prevention and Wound Care NeoGenomics Advances AI-Driven Oncology Insights at AACR Eli Lilly Reports Breakthrough Phase 3 Jaypirca Results Daiichi Sankyo Secures FDA Priority Review for ADC Therapy Allogene Therapeutics Reports Strong ALPHA3 Trial Data PDS Biotech Reports Breakthrough Phase 2 mCRC Results